| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/1998 | EP0821663A1 Fatty acid derivatives |
| 02/04/1998 | EP0821594A1 Compounds for cancer imaging and therapy |
| 02/04/1998 | EP0821589A1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/1998 | EP0821588A2 Levobupivacaine and its use as an anaesthetic in pregnant women |
| 02/04/1998 | EP0821587A1 Compositions, kits, and methods for administration of antilipemic and anti-platelet aggregation drugs |
| 02/04/1998 | EP0821586A1 A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers |
| 02/04/1998 | EP0821585A1 USE OF $g(a) 1L? AGONISTS IN THE TREATMENT OF INCONTINENCE |
| 02/04/1998 | EP0821584A1 2,4-dichlorobenzyl alcohol and amylmetacresol against hiv infection |
| 02/04/1998 | EP0821582A2 Controlled release tablet |
| 02/04/1998 | EP0821572A1 Magnesium taurate as a therapeutic agent |
| 02/04/1998 | EP0821551A1 Screening assay for the identification of inhibitors of macrophage migration inhibitory factor |
| 02/04/1998 | EP0750499A4 Carbanilide anticoccidials |
| 02/04/1998 | EP0675721B1 Pharmaceutical compositions comprising contignasterol compounds |
| 02/04/1998 | EP0667856B1 Novel vitamin d analogues |
| 02/04/1998 | EP0655916B1 Transdermal application agent containing 3-keto-desogestrel |
| 02/04/1998 | EP0460072B1 Human elastase inhibitor |
| 02/04/1998 | CN1172485A Meso-monoiodo-substituted tetramacrocyclic compounds and methods for making and using the same |
| 02/04/1998 | CN1172484A Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials |
| 02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 02/04/1998 | CN1172482A Antipsychotic 4 (1 H -indolyl -1 -YL) -1 -substituted piperidine derivatives |
| 02/04/1998 | CN1172475A Antiarrhythmic (S) -enantiomers of methanesulfonamides |
| 02/04/1998 | CN1172469A 2 -aminoindans as selective dopamine D3 ligands |
| 02/04/1998 | CN1172435A Use of non-mammalian DNA virus to express exogenous gene in mammalian cell |
| 02/04/1998 | CN1172433A Sucralfate preparation |
| 02/04/1998 | CN1172432A Method of decreasing serum calcium levels |
| 02/04/1998 | CN1172431A Use of melatonin for treating patients suffering from drug addiction |
| 02/04/1998 | CN1172430A Plaster containing estradiol |
| 02/04/1998 | CN1172104A Substituted lndanylidineacetylguanidines, process for their preparation, their use as medicaments of diagnostic and medicaments containing them |
| 02/04/1998 | CN1171965A Tianjing Busuiye medicinal liquid and its preparing method |
| 02/04/1998 | CN1171952A Traditional Chinese medicine preparation for eradicating Helicobacter phlori |
| 02/04/1998 | CN1171938A Detoxicating slow release capsule |
| 02/04/1998 | CN1171937A Methods of inducing analgesia or anesthesia and treating or preventing ischemic injury of tissues in general |
| 02/04/1998 | CN1037269C Method for preparing 3 -quinuclidinyl ester |
| 02/04/1998 | CN1037268C Method for preparation of antipicornaviral phridazinamines |
| 02/04/1998 | CN1037267C Method for preparation of tri-substituted tetrahydrofuran derivative |
| 02/04/1998 | CN1037266C Quinoline derivative fumarates and its preparing method and its medicinal composition |
| 02/04/1998 | CN1037235C Use of 6-(substituted amino) purine cytokinin in preparation of antisenlity composition |
| 02/03/1998 | USRE35724 Administering estrogen contraceptive orally to human female daily from day 3 or 4 through day 7 of menstrual cyle, then follow-up composition containing progestin |
| 02/03/1998 | US5714630 Reacting a serine salt with an activated hydrocarbon derivative in the presence of a phase transfer agent |
| 02/03/1998 | US5714621 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 02/03/1998 | US5714615 Acetylcholinesterase enzyme inhibitor, stimulate nicotinic receptors in central nervous system |
| 02/03/1998 | US5714609 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 02/03/1998 | US5714608 1-substituted 1H-imidazo- 4,5-c!quinolin-4-amines |
| 02/03/1998 | US5714607 Process improvement in the synthesis of N- 3-(3-cyano-pyrazolo 1,5-a!pyrimidin-7-yl)phenyl!-N-ethylacetamide |
| 02/03/1998 | US5714606 Pyrrolidine-containing monomers and oligomers |
| 02/03/1998 | US5714605 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 02/03/1998 | US5714520 Propofol compostion containing edetate |
| 02/03/1998 | US5714519 Administering pantethine at predetermined time of day |
| 02/03/1998 | US5714516 Administering 2-hydroxymyristic acid or pentadecanoic or hexadecanoic acids 2-substituted with hydroxy or bromine as nontoxic agent against herpes virus |
| 02/03/1998 | US5714515 Pharmaceutical alpha-keto carboxylic acid compositions, method of making and use thereof |
| 02/03/1998 | US5714514 2-Cyano-3-mercaptocrotonamides |
| 02/03/1998 | US5714512 Solution in a surfactant; for perfusions |
| 02/03/1998 | US5714511 Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs |
| 02/03/1998 | US5714510 Topical proxyl composition and method |
| 02/03/1998 | US5714508 Inhibitors of angiotensin ii |
| 02/03/1998 | US5714505 Method for treatment of psoriasis, by omeprazole or related compounds |
| 02/03/1998 | US5714504 Alkaline salts of omeprazole; antiulcer agents; magnesium omeprazole or sodium omeprazole for example |
| 02/03/1998 | US5714503 Compounds and methods for inhibition of HIV and related viruses |
| 02/03/1998 | US5714502 Atypical neuraleptics having no cataleptic side effects; schizophrenia, antidepressants; analgesics; hypotensive agents; extrapyramidal disorders |
| 02/03/1998 | US5714501 Antiallergenic/antiasthmatic agents |
| 02/03/1998 | US5714500 2-phenyl- and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
| 02/03/1998 | US5714498 Benzimidazole derivatives |
| 02/03/1998 | US5714496 Quinuclidine derivatives as squalene synthase inhibitors |
| 02/03/1998 | US5714495 Anxiolytic agents, melatonin receptors for treating psychological disorders and analgesics, sleep disorders |
| 02/03/1998 | US5714494 For treating atherosclerosis |
| 02/03/1998 | US5714493 Antiinflammatory agent |
| 02/03/1998 | US5714491 Anticancer and antitumor agent |
| 02/03/1998 | US5714490 4-(4-(4-(-((5-(2,4-dihalophenyl)--tetrahydro-5-(1h-1,2,4-triazol-1-ylmethyl)tetrahydrofur-3-yl)methoxy)phenyl)-2,4-dihydro-2-(mono- or dihydroxyalkyl)-3h-1,2,4-triazol-3-one; broad spectrum; water solubility; aspergillus; candida |
| 02/03/1998 | US5714489 2,3(1H,4H)quinoxalinedione |
| 02/03/1998 | US5714487 2,7-substituted octahydro-pyrrolo 1,2-a!pyrazine derivatives |
| 02/03/1998 | US5714486 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/03/1998 | US5714485 Piperidine and hexahydropyridazine thrombin inhibitors |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714483 Antitussive |
| 02/03/1998 | US5714482 Inhibiting the activity of oxygen and hydroxyl free radicals by administering stable spin label compounds which can bond to biomolecules, for treatment of alopecia |
| 02/03/1998 | US5714480 Treating cardiovascular disease with steroidal 5-alpha-reductase inhibitors |
| 02/03/1998 | US5714478 Topical application or injection of a sphingomyelin |
| 02/03/1998 | US5714477 Homogenous, aqueous solution containing fatty monoglyceride; enhanced absorption/bioavailability, drug delivery |
| 02/03/1998 | US5714473 Chemotherapy; mixture with alkali metal citrate |
| 02/03/1998 | US5714471 Useful in indicating neurodegenerative disorders characterized by deposition of cerebral amyloid |
| 02/03/1998 | US5714463 Use of growth factor and antimetabolite combination to prevent or retard fistula closure following glaucoma filtration surgery |
| 02/03/1998 | US5714353 Safe vectors for gene therapy |
| 02/03/1998 | US5714328 RNA photocleavage using texaphyrins |
| 02/03/1998 | US5714191 Pesticides used in medicated feedstuff, mineral salt lick or edible bait |
| 02/03/1998 | US5714169 Live yeast cell derivative |
| 02/03/1998 | US5714167 Reversibly forming supramolecular complex of active agent with perturbant; drug delivery |
| 02/03/1998 | US5714166 Bioactive and/or targeted dendrimer conjugates |
| 02/03/1998 | US5714165 Blend of polyoxyethylene glycol and water soluble salt of copolymer of methyl vinyl ether and maleic (acid or anhydride) |
| 02/03/1998 | US5714163 Vinca alkaloid vesicles with enhanced efficacy and tumor targeting properties |
| 02/03/1998 | US5714162 Scopolamine patch |
| 02/03/1998 | US5714155 Ethylenediamine derivative in a cosmetic or dermatological composition, and composition containing in particular a product having an irritant side effect |
| 02/03/1998 | US5714152 Herpes simplex virus VP16 vaccines |
| 02/03/1998 | US5714148 Chemical compounds |
| 02/03/1998 | US5713828 Hollow-tube brachytherapy device |
| 02/03/1998 | CA2128093C 4-aryl-3-(heteroarylureido)-1,2-dihydro-2-oxoquinoline derivatives as antihypercholesterolemic and antiatherosclerotic agents |
| 02/03/1998 | CA2100836E Pharmaceutical composition |
| 02/03/1998 | CA2098989C Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines |
| 02/03/1998 | CA2081564C Synergistic therapeutic compositions and methods |
| 02/03/1998 | CA2061567C Use of hyaluronic acid to repair ischemia reperfusion damage |
| 02/03/1998 | CA2044748C Pyrazolopyrimidinone antianginal agents |